Contrast Ultrasound Imaging in Liver Disease;Échographie de Contraste et Affections Hépatiques

Journal de Radiologie

Volumn 84, Issue 12 II, 2003, Pages 2025-2040

  Tranquart, F ^a   Bleuzen, A ^a   Correas, J M ^b   Kissel, A ^c   Tchuenbou, J ^a   Vandooren, E ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Centre de Radiologie   (France)

Author keywords

Hemangioma; Hepatocellular carcinoma; Liver; Metastasis; Ultrasonography; US contrast agent

Indexed keywords

ECHO CONTRAST MEDIUM; SHU 508; SONOVUE; CONTRAST MEDIUM;

CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; NONLINEAR SYSTEM; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; AGED; FEMALE; LIVER TUMOR; MALE; MIDDLE AGED; REPRODUCIBILITY;

AGED; CONTRAST MEDIA; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 1242317112     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M, Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance and artifacts. Eur Radiol 2001;11:1316-28.
2. Correas J, Claudon M, Lefevre F, Helenon O, Cattin F, Vilgrain V. Agents de contraste ultrasonores. J Radiol 2000;81:423-33.
3. Harvey CJ, Blomley MJ, Eckersley RJ, Cosgrove DO. Developments in ultrasound contrast media. Eur Radiol 2001;11:675-89.
4. Leen E, Horgan P. Ultrasound contrast agents for hepatic imaging with nonlinear modes. Curr Probl Diagn Radiol 2003;32:66-87.
5. Schneider M. Bubbles and microcirculatory disorders. Eur Radiol 2001;11:E1-5.
6. Forsberg F, Liu JB, Chiou HJ, Rawool NM, Parker L, Goldberg BB. Comparison of fundamental and wideband harmonic contrast imaging of liver tumors. Ultrasonics 2000;38:110-3.
7. Bauer A, Solbiati L, Weissman N. Ultrasound imaging with SonoVue: low mechanical index real-time imaging. Acad Radiol 2002 Aug;9 Suppl 2:S282-4.
8. Leen E. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 2001;11:E27-34.
9. Kindberg GM, Tolleshaug H, Roos N, Skotland T. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res 2003;312:49-54.
10. Forsberg F, Piccoli CW, Liu JB, Rawool NM, Merton DA, Mitchell DG, Goldberg BB. Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. Radiology 2002;222:824-9.
11. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001;11:E15-26.
12. Heckemann RA, Cosgrove DO, Blomley MJ, Eckersley RJ, Harvey CJ, Mine Y. Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material-early experience. Radiology 2000;216:592-6.
13. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000;35:58-71.
14. Lencioni R, Cioni D, Crocetti L, Donati F, Franchini C, Giusti S, Bartolozzi C. Ultrasound imaging of focal liver lesions with a second-generation contrast agent. Acad Radiol 2002 Aug; 9 Suppl 2:S371-4.
15. Quaia E, Stacul F, Bertolotto M, Locatelli M, Mucelli RP. Characterization of focal liver lesions with pulse inversion harmonic imaging (PIHI) using a second generation US contrast agent. Acad Radiol 2002 Aug; 9 Suppl 2:S376-9.
16. Harvey CJ, Albrecht T. Ultrasound of focal liver lesions. Eur Radiol 2001;11:1578-93.
17. Leen E. Ultrasound contrast harmonic imaging of abdominal organs. Semin Ultrasound CT MR. 2001;22:11-24.
18. Kim TK, Choi BY, Hong HS. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SHU 508 A: preliminary study. Ultrasound Med Biol 2000;26:1439-44.
19. Albrecht T, Overberg A, Hoffmann CW, Blomley MJ, Harvey CJ, Eckersley R, Schettler S, Wolf KJ. Characterization of focal liver lesions with phase inversion ultrasound during the late liver-specific phase of Levovist. Acad Radiol 2002;9:S375.
20. Hohmann J, Skrok J, Puls R, Albrecht T. Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2003;175:835-43.
21. Dalla Palma L, Bertolotto M, Quaia E, Locatelli M. Detection of liver metastases with pulse inversion harmonic imaging: preliminary results. Eur Radiol 1999;9:S382-7.
22. Fracanzani AL, Burdick L, Borzio M, Roncalli M, Bonelli N, Borzio F, Maraschi A, Fiorelli G, Fargion S. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology. 2001;34:1109-12.
23. Choi BI, Kim TK, Han JK, Kim AY, Seong CK, Park SJ. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Radiology 2000;214:381-6.
24. Furuse J, Nagase M, Ishii H, Yoshino M. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol 2003;76:385-92.
25. Kitamura H, Kawasaki S, Nakajima K, Ota H. Correlation between microbubble contrast-enhanced color doppler sonography and immunostaining for Kupffer cells in assessing the histopathologic grade of hepatocellular carcinoma: preliminary results. J Clin Ultrasound 2002;30:465-71.
26. Numata K, Tanaka K, Kiba T, et al. Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings. J Ultrasound Med 2001;20:89-98.
27. Hui CK, Yuen MF, Tso WK, Ng IO, Chan AO, Lai CL. Cholangiocarcinoma in liver cirrhosis. J Gastroenterol Hepatol 2003;18:337-41.
28. Quaia E, Bertolotto M, Dalla Palma L. Characterization of liver hemangiomas with pulse inversion harmonic imaging. Eur Radiol 2002;12:537-44.
29. Albrecht T, Blomley MJ. Characteristics of hepatic hemangiomas at contrast-enhanced harmonic US. Radiology 2001;220:269-70.
30. Meuwly JY, Schnyder P, Gudinchet F, Denys AL. Pulse-inversion harmonic imaging improves lesion conspicuity during US-guided biopsy. J Vasc Interv Radiol 2003;14:335-41.
31. Skjoldbye B, Pedersen MH, Struckmann J, Burcharth F, Larsen T. Improved detection and biopsy of solid liver lesions using pulse-inversion ultrasound scanning and contrast agent infusion. Ultrasound Med Biol 2002;28:439-44.
32. Numata K, Isozaki T, Ozawa Y, et al. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003;180:143-9.
33. Cioni D, Lencioni R, Rossi S, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. AJR Am J Roentgenol 2001;177:783-8.
34. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003;97:3027-35.
35. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-51.
36. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000;217:558-63.
37. Liu JB, Goldberg BB, Merton DA, Rawool NM, Needleman L, Forsberg F. The role of contrast-enhanced sonography for radiofrequency ablation of liver tumors. J Ultrasound Med. 2001;20:517-23.
38. Ramnarine KV, Leen E, Oppo K, Angerson WJ, McArdle CS. Contrast-enhanced Doppler perfusion index: clinical and experimental evaluation. J Ultrasound Med 2002;21:1121-9.
39. Kissel A, Rixe O, Methlin A, et al. Quantification of hepatic arterial and portal venous flow using ultrasound contrast agents for early detection of liver metastases of colorectal cancers. J Radiol 2001;82:1621-5.
40. Sugimoto H, Kaneko T, Hirota M, Tezel E, Nakao A. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol 2002;37:578-83.
41. Albrecht T, Blomley MJ, Cosgrove DO, et al. Transit-time studies with levovist in patients with and without hepatic cirrhosis: a promising new diagnostic tool. Eur Radiol 1999;9:S377-81.
42. Leen E. The detection of occult liver metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999;6:7-15.
43. Leen E, Goldberg JA, Angerson WJ, McArdle CS. Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 2000;355:34-7.
44. Aube C, Lebigot J. Échographie de contraste: place dans le diagnostic et la caractérisation des tumeurs du foie. Gastroentérologie Clin Biol 2003; S5: B63-B70.
45. Harvey CJ, Blomley MJ, Eckersley RJ, Heckemann RA, Butler-Barnes J, Cosgrove DO. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 2000;355:807-8.
46. Harvey CJ, Blomley MJ, Eckersley RJ, Cosgrove DO, Patel N, Heckemann RA, Butler-Barnes J. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience. Radiology 2000;216:903-8.
47. Wilson SR, Burns PN, Muradali D: Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterisation of haemangioma, hepatocellular carcinoma and metastasis. Radiology 2000;215:153-61.
48. Albrecht T, Blomley MJK, Burns PN, Wilson S, Harvey CJ, Leen E et al. Improved detection of hepatic metastases with pulse inversion ultrasonography during the liver specific phase of SHU 508 A (Levovist)- multi centre study. Radiology 2003;227:361-70.
49. Leen E, Angerson WJ, Yarmenitis S, et al. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002;41:200-6.
50. Bertolotto M, Dalla Palma L, Quaia E, Locatelli M. Characterisation of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 2000;10:1369-76.
51. Albrecht T, Hoffman CW, Schettler S, Schmitz S, Overberg A, Ilg M, Wolf KJ. Improved detection of liver metastases with pulse inversion ultrasound during the late phase of Levovist®. Eur Radiol 2002;9:S236-9.
52. Bernatik T, Strobel D, Hahn EG, Becker D. Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional echography. J Ultrasound Med 2001;20:509-15.
53. Blomley MJK, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SHU 508 A: early experience. Radiology 1999;210:409-16.
54. von Herbay A, Vogt C, Haussinger D. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 2002;179:1273-9.
55. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000;216:411-7.
56. Blomley MJ, Albrecht T, Cosgrove DO, et al. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999;25:1341-52.
57. Albrecht T, Hoffmann CW, Schettler S, Overberg A, IIg M, Wolf KJ. Improved detection of liver metastases with phase inversion imaging during the liver-specific phase of the ultrasound contrast agent levovist. Eur Radiol 1999;9:S388.
58. Quaia E, Bertolotto M, Forgacs B, Rimondini A, Locatelli M, Mucelli RP. Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol 2003;13:475-83.
59. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002;222:95-102.
60. Blomley MJ, Sidhu PS, Cosgrove DO, et al. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience. Radiology 2001;220:661-7.
61. Albrecht T, Hoffmann CW, Schmitz SA, et al. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol 2001;176:1191-8.
62. Albrecht T, Hoffmann CW, Schettler S, et al. Improved detection of liver metastases with phase inversion ultrasound during the late phase of levovist. Acad Radiol 2002;9:S236-9.
63. Yucel C, Ozdemir H, Gurel S, Ozer S, Arac M. Detection and differential diagnosis of hepatic masses using pulse inversion harmonic imaging during the liver-specific late phase of contrast enhancement with Levovist. J Clin Ultrasound 2002;30:203-12.
64. Rosenberg ML, Carpenter AP. Phase III DEFINITY Clinical Investigators. Contrast material-enhanced abdominal US examinations with DMP 115 (DEFINITY) provides additional diagnostic information with potential for changes in patient management. Acad Radiol 2002;9:S243-5.
65. Strobel D, Raeker S, Martus P, Hahn EG, Becker D. Phase inversion harmonic imaging versus contrast-enhanced power Doppler sonography for the characterization of focal liver lesions. Int J Colorectal Dis 2003;18:63-72.
66. Esteban JM, Molla MA, Tomas C, Maldonado L. Improved detection of liver metastases with contrast-enhanced wideband harmonic imaging: comparison with CT findings. Eur J Ultrasound 2002;15:119-26.
67. Koteish A, Thuluvath PJ. Screening for hepatocellular carcinoma. J Vasc Interv Radiol 2002;13:S185-90.
68. Kamel IR, Bluemke DA. Imaging evaluation of hepatocelullar carcinoma. J Vasc Interv Radiol 2002;13:S173-83.
69. Harvey CJ, Lim AK, Blomley MJ, Taylor-Robinson SD, Gedroyc WM, Cosgrove DO. Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. Eur Radiol 2002;12:S70-3.